[Trial of device that is not approved or cleared by the U.S. FDA]

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

NCT06178991 ·Status: COMPLETED ·Phase: PHASE3

Clinical Performance of the Diassess Influenza A and B Test

NCT03035396 ·Status: COMPLETED ·Phase: NA

FLU A+B Nasal Swab Clinical Study

NCT00636662 ·Status: COMPLETED

Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults

NCT06125691 ·Status: COMPLETED ·Phase: PHASE1

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

NCT04579588 ·Status: RECRUITING

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

NCT04288921 ·Status: UNKNOWN ·Phase: NA

Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test

NCT07190131 ·Status: COMPLETED

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza

NCT05596734 ·Status: COMPLETED ·Phase: PHASE2

A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults

NCT05827926 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults

NCT06602531 ·Status: COMPLETED ·Phase: PHASE1

Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer

NCT02067286 ·Status: COMPLETED

A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza

NCT05160636 ·Status: ACTIVE_NOT_RECRUITING

Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults

NCT06279871 ·Status: COMPLETED ·Phase: PHASE3

A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.

NCT06163677 ·Status: WITHDRAWN

Covid-19 and Influenza Oral Vaccine Study

NCT06355232 ·Status: RECRUITING ·Phase: PHASE1

Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model

NCT03180801 ·Status: COMPLETED ·Phase: PHASE2

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

NCT05827978 ·Status: COMPLETED ·Phase: PHASE3

QuickVue Influenza A+B Clinical Field Trial

NCT00491283 ·Status: COMPLETED ·Phase: NA

A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza

NCT05227001 ·Status: COMPLETED ·Phase: PHASE1

A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

NCT06680375 ·Status: COMPLETED ·Phase: PHASE1

Influenza Diagnosis, Treatment and Surveillance With Xpert Flu

NCT01947049 ·Status: COMPLETED ·Phase: NA

Dose, Safety, and Pathogenicity of a New Influenza B Strain

NCT06254820 ·Status: RECRUITING ·Phase: PHASE2

Influenza Viral Challenge Study of CC-42344 in Healthy Participants

NCT06160531 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge

NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B

NCT01753531 ·Status: COMPLETED